Professor, J. David Gladstone Institute of Cardiovascular Disease
President and CEO, Biocom
CEO, Alnylam Pharmaceuticals
Associate Vice Chancellor, UCSD
Senior Managing Partner, Aisling Capital Fund
Founder and CEO, Esperion Therapeutics
CEO and Managing Partner, Detroit Venture Partners
Professor, Michigan State University
|
|